4.1 Article

Effect of Cognitive Reserve Markers on Alzheimer Pathologic Progression

期刊

ALZHEIMER DISEASE & ASSOCIATED DISORDERS
卷 27, 期 4, 页码 343-350

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/WAD.0b013e3182900b2b

关键词

cognitive reserve; Alzheimer disease; aging; biomarker; longitudinal study

资金

  1. ADNI (National Institutes of Health) [U01 AG024904]
  2. National Institute on Aging
  3. National Institute of Biomedical Imaging and Bioengineering
  4. Abbott
  5. Alzheimer's Association
  6. Alzheimer's Drug Discovery Foundation
  7. Amorfix Life Sciences Ltd.
  8. AstraZeneca
  9. Bayer HealthCare
  10. BioClinica Inc.
  11. Biogen Idec Inc.
  12. Bristol-Myers Squibb Company
  13. Eisai Inc.
  14. Elan Pharmaceuticals Inc.
  15. Eli Lilly and Company
  16. F. Hoffmann-La Roche Ltd.
  17. Genentech Inc.
  18. GE Healthcare
  19. Innogenetics N.V.
  20. Janssen Alzheimer Immunotherapy Research & Development LLC.
  21. Johnson & Johnson Pharmaceutical Research & Development LLC.
  22. Medpace Inc.
  23. Merck Co. Inc.
  24. Meso Scale Diagnostics LLC.
  25. Novartis Pharmaceuticals Corporation
  26. Pfizer Inc.
  27. Servier
  28. Synarc Inc.
  29. Takeda Pharmaceutical Company
  30. Canadian Institutes of Health Research
  31. NIH [P30 AG010129, K01 AG030514, AG027859, AG027984, AG 024904]
  32. Dana Foundation

向作者/读者索取更多资源

Education, occupation, premorbid intelligence, and brain size are surrogate markers for cognitive reserve. Whether these markers have biological influence on Alzheimer disease (AD) pathology is not known. We thus aimed to investigate the effect of cognitive reserve proxies on longitudinal change of AD biomarkers. A total of 819 participants with normal cognition, mild cognitive impairment, and mild AD were enrolled in the Alzheimer's Disease Neuroimaging Initiative and followed up with repeated measures of cerebrospinal fluid, positron emission tomography, and magnetic resonance imaging biomarkers. Generalized estimating equations were used to assess whether biomarker rates of change were modified by reserve proxies. Cerebrospinal fluid A(42) decline was slower in normal cognition participants with higher cognitive reserve indexed by education, occupation, and American National Adult Reading Test (ANART). The decline of [F-18] fluorodeoxyglucose positron emission tomography uptake was slower in AD participants with better performance on the ANART. Education, occupation, and ANART did not modify the rates of magnetic resonance imaging hippocampal atrophy in any group. These findings remained unchanged after accounting for APOE 4, longitudinal missing data, and baseline cognitive performance. Higher levels of reserve markers may slow the rate of amyloid deposition before cognitive impairment and preserve glucose metabolism at the dementia stage over the course of AD pathologic progression.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据